BCR/ABL and other kinases from chronic myeloproliferative disorders stimulate single-strand annealing, an unfaithful DNA double-strand break repair

被引:79
作者
Cramer, Kimberly [1 ,2 ]
Nieborowska-Skorska, Margaret [1 ]
Koptyra, Mateusz [1 ]
Slupianek, Artur [1 ]
Penserga, Emir Tyrone P. [1 ]
Eaves, Connie J. [3 ]
Aulitzky, Walter [4 ]
Skorski, Tomasz [1 ]
机构
[1] Temple Univ, Sch Med, Dept Microbiol & Immunol, MRB, Philadelphia, PA 19140 USA
[2] Temple Univ, Dept Biol, Philadelphia, PA 19122 USA
[3] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada
[4] Robert Bosch Krankenhaus, Dept Internal Med Oncol & Hematol 2, Stuttgart, Germany
关键词
D O I
10.1158/0008-5472.CAN-08-1101
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Myeloproliferative disorders (MPD) are stem cell-derived clonal diseases arising as a consequence of acquired aberrations in c-ABL, Janus-activated kinase 2 (JAK2), and platelet-derived growth factor receptor (PDGFR) that generate oncogenic fusion tyrosine kinases (FTK), including BCR/ABL, TEL/ABL, TEL/JAK2, and TEL/PDGF beta R. Here, we show that FTKs stimulate the formation of reactive oxygen species and DNA double-strand breaks (DSB) both in hematopoietic cell lines and in CD34(+) leukemic stem/progenitor cells from patients with chronic myelogenous leukemia (CML). Single-strand annealing (SSA) represents a relatively rare])of. very unfaithful DSB repair mechanism causing chromosomal aberrations. Using a specific reporter cassette integrated into genomic DNA, we found that BCR/ABL, and other FTKs stimulated SSA activity. Imatinib-mediated inhibition of BCR/ABL abrogated this effect, implicating a kinase-dependent mechanism. Y253F, F255K, T3151, and 14396P mutants of BCR/ABL that confer imatinib resistance also stimulated SSA. Increased expression of either nonmutated or mutated BCR/ABL kinase, as is typical of blast phase cells and very primitive chronic phase CML cells, was associated with higher SSA activity. BCR/ABL-mediated stimulation of SSA was accompanied by enhanced nuclear colocalization of RAD52 and ERCC1, which play it key role in the repair. Taken together, these findings suggest a role of FTKs in causing disease progression in MPDs by inducing chromosomal instability through the production of DSBs and stimulation of SSA repair.
引用
收藏
页码:6884 / 6888
页数:5
相关论文
共 20 条
  • [1] Additional clonal abnormalities in Philadelphia-positive ALL and CML demonstrate a different cytogenetic pattern at diagnosis and follow different pathways at progression
    Bacher, U
    Haferlach, T
    Hiddemann, W
    Schnittger, S
    Kern, W
    Schoch, C
    [J]. CANCER GENETICS AND CYTOGENETICS, 2005, 157 (01) : 53 - 61
  • [2] Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction
    Copland, Mhairi
    Hamilton, Ashley
    EIrick, Lucy J.
    Baird, Janet W.
    Allan, Elaine K.
    Jordanides, Niove
    Barow, Martin
    Mountford, Joanne C.
    Holyoake, Tessa L.
    [J]. BLOOD, 2006, 107 (11) : 4532 - 4539
  • [3] Chromosomal translocation mechanisms at intronic Alu elements in mammalian cells
    Elliott, B
    Richardson, C
    Jasin, M
    [J]. MOLECULAR CELL, 2005, 17 (06) : 885 - 894
  • [4] PROGNOSTIC FACTORS IN ADULT CHRONIC MYELOMONOCYTIC LEUKEMIA - AN ANALYSIS OF 107 CASES
    FENAUX, P
    BEUSCART, R
    LAI, JL
    JOUET, JP
    BAUTERS, F
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (09) : 1417 - 1424
  • [5] Kinase domain mutants of Bcr-Abl exhibit altered transformation potency, kinase activity, and substrate utilization, irrespective of sensitivity to imatinib
    Griswold, Ian J.
    MacPartlin, Mary
    Bumm, Thomas
    Goss, Valerie L.
    O'Hare, Thomas
    Lee, Kimberly A.
    Corbin, Amie S.
    Stoffregen, Eric P.
    Smith, Caitlyn
    Johnson, Kara
    Moseson, Erika M.
    Wood, Lisa J.
    Polakiewicz, Roberto D.
    Druker, Brian J.
    Deininger, Michael W.
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2006, 26 (16) : 6082 - 6093
  • [6] Clinical, hematological and cytogenetic characteristics of atypical chronic myeloid leukemia
    Hernández, JM
    del Cañizo, MC
    Cuneo, A
    García, JL
    Gutiérrez, NC
    González, M
    Castoldi, G
    San Miguel, JF
    [J]. ANNALS OF ONCOLOGY, 2000, 11 (04) : 441 - 444
  • [7] Primary chromosomal rearrangements of leukemia are frequently accompanied by extensive submicroscopic deletions and may lead to altered prognosis
    Kolomietz, E
    Al-Maghrabi, J
    Brennan, S
    Karaskova, J
    Minkin, S
    Lipton, J
    Squire, JA
    [J]. BLOOD, 2001, 97 (11) : 3581 - 3588
  • [8] BCR/ABL kinase induces self-mutagenesis via reactive oxygen species to encode imatinib resistance
    Koptyra, Mateusz
    Falinski, Rafal
    Nowicki, Michal O.
    Stoklosa, Tomasz
    Majsterek, Ireneusz
    Nieborowska-Skorska, Margaret
    Blasiak, Janusz
    Skorski, Tomasz
    [J]. BLOOD, 2006, 108 (01) : 319 - 327
  • [9] Physical and functional interaction between the XPF/ERCC1 endonuclease and hRad52
    Motycka, TA
    Bessho, T
    Post, SM
    Sung, P
    Tomkinson, AE
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (14) : 13634 - 13639
  • [10] The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR/ABL-regulated SET protein
    Neviani, P
    Santhanam, R
    Trotta, R
    Notari, M
    Blaser, BW
    Liu, SJ
    Mao, H
    Chang, JS
    Galietta, A
    Uttam, A
    Roy, DC
    Valtieri, M
    Bruner-Klisovic, R
    Caligiuri, MA
    Bloomfield, CD
    Marcucci, G
    Perrotti, D
    [J]. CANCER CELL, 2005, 8 (05) : 355 - 368